Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Michaelis

Showing results (211-220 of 214) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 214 results.
Nature Medicine|December 20, 2016
SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemiaConstanze Schneider, Thomas Oellerich, Hanna-Mari Baldauf, et al.
Nature Communications|October 7, 2022
Integrated analysis of cervical squamous cell carcinoma cohorts from three continents reveals conserved subtypes of prognostic significanceAnkur Chakravarthy, Ian Reddin, Stephen Henderson, et al.
The Lancet. Oncology|June 30, 2025
Carcinogenicity of hepatitis D virus, human cytomegalovirus, and Merkel cell polyomavirusMargaret R Karagas, John Kaldor, Martin Michaelis, et al.
Plos One|February 14, 2017
Acquired resistance to oxaliplatin is not directly associated with increased resistance to DNA damage in SK-N-ASrOXALI4000, a newly established oxaliplatin-resistant sub-line of the neuroblastoma cell line SK-N-ASEmily Saintas, Liam Abrahams, Gulshan T Ahmad, et al.
Pageof 22

Showing results (211-220 of 214) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 214 results.
Nature Medicine|December 20, 2016
SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemiaConstanze Schneider, Thomas Oellerich, Hanna-Mari Baldauf, et al.
Nature Communications|October 7, 2022
Integrated analysis of cervical squamous cell carcinoma cohorts from three continents reveals conserved subtypes of prognostic significanceAnkur Chakravarthy, Ian Reddin, Stephen Henderson, et al.
The Lancet. Oncology|June 30, 2025
Carcinogenicity of hepatitis D virus, human cytomegalovirus, and Merkel cell polyomavirusMargaret R Karagas, John Kaldor, Martin Michaelis, et al.
Plos One|February 14, 2017
Acquired resistance to oxaliplatin is not directly associated with increased resistance to DNA damage in SK-N-ASrOXALI4000, a newly established oxaliplatin-resistant sub-line of the neuroblastoma cell line SK-N-ASEmily Saintas, Liam Abrahams, Gulshan T Ahmad, et al.
Pageof 22